Business Context and Reporting Period
Company: New America Acquisition I Corp. (a Special Purpose Acquisition Company or "SPAC")
Reporting Period: Fiscal year ended December 31, 2025 (Inception: May 28, 2025)
Status: Blank check company with no operating history or revenues. All activity relates to formation, the Initial Public Offering (IPO), and the search for an initial business combination.
Strategy: Targeting U.S.-based businesses in technology, healthcare, and logistics with an enterprise value of $700 million or greater to advance U.S. industrial capacity and innovation.
Key Financial Metrics
| Metric | Value |
|---|---|
| Trust Account Balance | $345,917,508 (Includes $917,508 interest income) |
| Cash Outside Trust | $944,106 |
| Total Assets | $347,460,979 |
| Net Income | $477,607 |
| Operating Costs | $207,359 |
| Income Tax Expense | $232,542 |
| Working Capital | $1,007,511 |
| Debt | $0 (Promissory note fully repaid at IPO closing) |
Material Changes and IPO Details
- IPO Completion: On December 5, 2025, the Company completed an IPO of 34,500,000 units at $10.00 per unit, generating gross proceeds of $345,000,000. The underwriters fully exercised their over-allotment option.
- Private Placement: Simultaneously, the Sponsor purchased 600,000 private placement units for $6,000,000.
- Trust Funding: $345,000,000 was deposited into a Trust Account, invested in U.S. government treasury obligations or money market funds.
- Transaction Costs: Total transaction costs were $26,926,783, comprising a $3,000,000 cash underwriting fee, $22,000,000 in fair value for representative shares issued to underwriters, and $1,926,783 in other offering costs.
- Share Structure: As of December 31, 2025, there were 34,500,000 Class A shares subject to redemption and 12,500,000 Class B founder shares outstanding.
Guidance, Outlook, and Risks
- Completion Window: The Company has 18 months from the IPO closing (or 24 months if a definitive agreement is executed within 18 months) to consummate an initial business combination. If unsuccessful, the Company will liquidate and redeem public shares.
- Redemption Rights: Public stockholders may redeem shares for a pro rata portion of the Trust Account (initially ~$10.00 per share plus interest). Sponsor and management have waived redemption rights for founder and private shares.
- Deferred Fees: A business combination marketing fee of up to 5.0% of gross proceeds ($17,250,000) is payable to underwriters upon completion of a business combination.
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of December 31, 2025, due to a lack of segregation of duties and insufficient written policies.
- Risk Factors: Significant risks include the inability to complete a business combination, potential dilution to public shareholders due to founder share conversion and warrant exercise, and the possibility that third-party claims could reduce the Trust Account balance below $10.00 per share.
Investor Verification Checklist
- Trust Account Integrity: Verify that the $345,917,508 in the Trust Account remains invested in permitted U.S. government securities and has not been encumbered.
- Internal Control Remediation: Assess the Company's plan to remediate the material weakness in internal controls over financial reporting identified in Item 9A.
- Related Party Transactions: Monitor the $20,000 monthly administrative fee paid to the Sponsor and any potential working capital loans (up to $2.5 million convertible) that may be drawn.
- Extension Provisions: Review the terms under which the Company may seek stockholder approval to extend the completion window beyond 24 months.
- Target Criteria: Confirm that any proposed target business meets the 80% of net assets test required by NYSE rules and aligns with the stated focus on U.S. industrial capacity.